Literature DB >> 32999030

Interferon-Induced Transmembrane Protein 3 Is a Virus-Associated Protein Which Suppresses Porcine Reproductive and Respiratory Syndrome Virus Replication by Blocking Viral Membrane Fusion.

Angke Zhang1, Hong Duan2, Huijun Zhao1, Huancheng Liao1, Yongkun Du1, Liangliang Li3, Dawei Jiang1, Bo Wan1, Yanan Wu1, Pengchao Ji1, En-Min Zhou4, Gaiping Zhang5,2,6.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) infection eliminates production of type I interferons (IFNs) in host cells, which triggers an antiviral immune response through the induction of downstream IFN-stimulated genes (ISGs), thus escaping the fate of host-mediated clearance. The IFN-induced transmembrane 3 (IFITM3) has recently been identified as an ISG and plays a pivotal role against enveloped RNA viruses by restricting cell entry. However, the role of IFITM3 in PRRSV replication is unknown. The present study demonstrated that overexpression of IFITM3 suppresses PRRSV replication, while silencing of endogenous IFITM3 prominently promoted PRRSV replication. Additionally, it was shown that IFITM3 undergoes S-palmitoylation and ubiquitination modification, and both posttranslational modifications contribute to the anti-PRRSV activity of IFITM3. Further study showed that PRRSV particles are transported into endosomes and then into lysosomes during the early stages of infection, and confocal microscopy results revealed that PRRSV particles are transported to IFITM3-positive cellular vesicles. By using a single virus particle fluorescent labeling technique, we confirmed that IFITM3 can restrict PRRSV membrane fusion by inducing accumulation of cholesterol in cellular vesicles. Additionally, we found that both endogenous and exogenous IFITM3 are incorporated into newly producing PRRS virions and diminish viral intrinsic infectivity. By using cell coculture systems, we found that IFITM3 effectively restricted PRRSV intercellular transmission, which may have been caused by disrupted membrane fusion and reduced viral infectivity. In conclusion, our results demonstrate, for the first time, that swine IFITM3 interferes with the life cycle of PRRSV, and possibly other enveloped arteritis viruses, at multiple steps.IMPORTANCE Porcine reproductive and respiratory syndrome (PRRS), which is caused by PRRS virus (PRRSV), is of great economic significance to the swine industry. Due to the complicated immune escape mechanisms of PRRSV, there are no effective vaccines or therapeutic drugs currently available against PRRS. Identification of cellular factors and underlying mechanisms that establish an effective antiviral state against PRRSV can provide unique strategies for developing antiviral vaccines or drugs. As an interferon (IFN)-stimulated gene, the role of IFN-induced transmembrane 3 (IFITM3) in PRRSV infection has not been reported as of yet. In the present study, it was shown that IFITM3 can exert a potent anti-PRRSV effect, and PRRS virions are trafficked to IFITM3-containing cell vesicles, where viral membrane fusion is impaired by cholesterol accumulation that is induced by IFITM3. Additionally, both endogenous and exogenous IFITM3 are incorporated into newly assembled progeny virions, and this decreased their intrinsic infectivity.
Copyright © 2020 Zhang et al.

Entities:  

Keywords:  IFITM3; PRRSV; cellular vesicles; cholesterol; membrane fusion

Year:  2020        PMID: 32999030     DOI: 10.1128/JVI.01350-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  8 in total

1.  Porcine reproductive and respiratory syndrome virus non-structural protein 4 cleaves guanylate-binding protein 1 via its cysteine proteinase activity to antagonize GBP1 antiviral effect.

Authors:  Hong Duan; Haoxin Dong; Shuya Wu; Jiahui Ren; Mingfang Zhang; Chuangwei Chen; Yongkun Du; Gaiping Zhang; Angke Zhang
Journal:  Vet Res       Date:  2022-07-08       Impact factor: 3.829

Review 2.  Positive Regulation of the Antiviral Activity of Interferon-Induced Transmembrane Protein 3 by S-Palmitoylation.

Authors:  Shubo Wen; Yang Song; Chang Li; Ningyi Jin; Jingbo Zhai; Huijun Lu
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

3.  Host Cells Actively Resist Porcine Reproductive and Respiratory Syndrome Virus Infection via the IRF8-MicroRNA-10a-SRP14 Regulatory Pathway.

Authors:  Zifang Zheng; Xiali Fu; Xue Ling; Huanhuan Sun; Yang Li; Zhiqian Ma; Bingjie Wei; Haixue Zheng; Shuqi Xiao
Journal:  J Virol       Date:  2022-03-16       Impact factor: 6.549

4.  Proteomic Investigation Reveals Eukaryotic Translation Initiation Factor 5A Involvement in Porcine Reproductive and Respiratory Syndrome Virus Infection in vitro.

Authors:  Huawei Li; Bo Wan; Dawei Jiang; Pengchao Ji; Mengmeng Zhao; Xinfeng Li; Rui Li; Songlin Qiao
Journal:  Front Vet Sci       Date:  2022-04-13

5.  Porcine reproductive and respiratory syndrome virus nsp4 positively regulates cellular cholesterol to inhibit type I interferon production.

Authors:  Wenting Ke; Yanrong Zhou; Yinan Lai; Siwen Long; Liurong Fang; Shaobo Xiao
Journal:  Redox Biol       Date:  2021-12-08       Impact factor: 11.799

6.  Swine Interferon-Inducible Transmembrane Proteins Potently Inhibit African Swine Fever Virus Replication.

Authors:  Siqi Cai; Zezhong Zheng; JiaoJiao Cheng; Lintao Zhong; Ran Shao; Feiyan Zheng; Zhiying Lai; Jiajun Ou; Liang Xu; Pei Zhou; Gang Lu; Guihong Zhang
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

7.  Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19.

Authors:  Noemi Veraldi; Romain R Vivès; Géraldine Blanchard-Rohner; Arnaud G L'Huillier; Noemie Wagner; Marie Rohr; Maurice Beghetti; Ariane De Agostini; Serge Grazioli
Journal:  J Mol Med (Berl)       Date:  2022-03-26       Impact factor: 5.606

8.  ARF1 with Sec7 Domain-Dependent GBF1 Activates Coatomer Protein I To Support Classical Swine Fever Virus Entry.

Authors:  Liang Zhang; Tao Wang; Yanyan Yi; Mengzhao Song; Mingxing Jin; Kangkang Guo; Yanming Zhang
Journal:  J Virol       Date:  2022-01-19       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.